Haupt Pharma Wülfling GmbH (manufacturing of unpackaged products, primary and secondary packaging)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of ulcerative colitis (from mild to moderate severity), as well as for the maintenance of remission in this disease. It is also used in Crohn's disease.
Dosage form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 400 mg ATC: A07EC02
-
The drug is used for the treatment of ulcerative colitis (from mild to moderate) and Crohn's disease. It is also used to maintain remission in ulcerative colitis.
Dosage form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 800 mg ATC: A07EC02